RCM
AMPE

Rotella Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Rotella Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-51
Closed -$45K – 612
2015
Q3 		$45K Buy
+51
New +$42.7K 0.01% 502

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CP
Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return

Rotella Capital Management's AMPE Position: Q4 2015 in Review

Rotella Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2015, closing a stake of 51 shares — an estimated $45K sold.

Rotella Capital Management first reported a position in AMPE in Q3 2015 and held it in 1 quarter. The position peaked at $45K in Q3 2015. 57 funds tracked by Wall St. Rank hold AMPE as of Q4 2015.

  • Rotella Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2015 after selling out during the quarter.
  • Rotella Capital Management sold 51 Ampio Pharmaceuticals Inc. shares in Q4 2015, an estimated $45K.
  • Rotella Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2015 and held it in 1 quarter.
  • Rotella Capital Management's Ampio Pharmaceuticals Inc. position peaked at $45K in Q3 2015.
  • 57 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2015.

Based on Rotella Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.